You are here

Willow Biosciences Inc.

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
WLLW
CSE Index: 
Currency: 

Willow Biosciences are pioneers in the biotechnology sector and have developed the only fully-integrated synthetic biology solution for opioid biosynthesis. We are now leveraging our unique design-build process to the biosynthesis of cannabinoids.

You are here

Willow Biosciences Inc. (WLLW)

SEDAR Information

Company Info

Address
3655 36th Street NW
Calgary, AB T2L 1Y8
Canada
Phone
403-669-4848
Fax
1-587-779-6149
Email
info@willowbio.com
Website
http://www.willowbio.com
Listing date
Thursday, September 14, 2017
Transfer Agent
Alliance Trust Company
Auditor
KPMG LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
78,891,879
Reserved for Issuance: 
33,524,529

Company Officers

Trevor Peters, President and Chief Executive Officer
Travis Doupe, Chief Financial Officer
Peter Facchini, Chief Scientific Officer
Jerry Ericsson, Vice President, Operations
Jill Hagel, Vice President, Applied Science
Mathias Schuetz, Vice President, Research and Development
Troy Talkkari, Vice President, Corporate Development
Joseph Tucker, Executive Chairman

Bulletins

03/12/2019

2019-1202 - Delist – Willow Biosciences Inc. (WLLW)

Le 3 decembre/December 2019

The common shares of Willow Biosciences Inc. will be delisted at the market close Wednesday, December 4, 2019.

Willow Biosciences has announced that the shares will continue to trade on the Toronto Stock Exchange.

___________________________

Les actions ordinaires de Willow Biosciences Inc. seront radiées de la cote à la fermeture des marchés le mercredi 4 décembre 2019.

Willow Biosciences a annoncé que les actions continueraient d'être négociées à la Bourse de Toronto.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Summit on Responsible Investment

Summit on Responsible Investment

Tuesday, June 27, 2023 -
9:00am to 7:00pm